Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of TQ-A3334 plus nucleos(t)ide analogs in treatment-naive or previously treated chronic hepatitis B
CTR20244362Phase 2Active
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tq-a3334 in Chronic Hepatitis B (CHB), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Dec 2024; status: active.
02
Drugs
tq-a3334
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20244362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244362.